Lilia Taningco

Lilia Taningco currently serves as the Director, Clinical Science Lead for Hematology in Global Clinical R&D at Bristol Myers Squibb since June 2021. Prior to this role, Lilia held various significant positions including Director of Immuno-Oncology and Principal Clinical Research Scientist at Celgene from January 2018 to May 2021, and Associate Director, Clinical Programs Lead at Shire from September 2015 to 2018. Lilia's extensive experience in oncology includes roles as Clinical Trial Head and Clinical Trial Lead at Novartis between January 2008 and August 2015, and Project Manager for Cardiovascular and CNS at Mitsubishi Pharma America from July 2005 to December 2007. Earlier career positions include Manager of Clinical Operations at Eisai Medical Research and Clinical Research Associate at PRA International. Lilia began the professional journey as a Research Assistant at Covance and Study Monitor at Huntingdon Life Sciences. Lilia earned a BS in Biology with a focus on Neuroscience from Rutgers University from 1993 to 1998.